Cargando…

COVID-19 and the liver: A brief and core review

Coronavirus disease 2019 has a wide range of clinical spectrum from asymptomatic infection to severe infection resulting in death within a short time. Currently, it is known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) does not only cause a respiratory tract infection but a more...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kayaaslan, Bircan, Guner, Rahmet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727220/ https://www.ncbi.nlm.nih.gov/pubmed/35070005 http://dx.doi.org/10.4254/wjh.v13.i12.2013

Ejemplares similares

Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017)

Effect of 2 Different High-Dose Methylprednisolone Treatments on Clinical Outcomes in Severe COVID-19 Patients
por: Eser, Fatma, et al.
Publicado: (2023)

Comparison of Antibiotic Regimens in Intra-abdominal Infections
por: Hasanoglu, Imran, et al.
Publicado: (2017)

COVID-19-induced liver injury in adult patients: A brief overview
por: Grando, Martina, et al.
Publicado: (2022)

Investigation of the relation between risk assessment of exposure and nosocomial SARS-CoV-2 transmission in healthcare workers: a prospective single-centre study
por: Kaya Kalem, Ayse, et al.
Publicado: (2022)

Investigation of SARS-CoV-2 using RT-PCR in vaginal swab samples of female patients with a diagnosis of severe COVID-19
por: Erdem, Deniz, et al.
Publicado: (2023)

A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol
por: Kalem, Ayse Kaya, et al.
Publicado: (2021)

COVID-19 patients with altered steroid hormone levels are more likely to have higher disease severity
por: Sezer, Sevilay, et al.
Publicado: (2022)

Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg
por: Hasanoglu, Imran, et al.
Publicado: (2020)

Reply to letter to the editor: “Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019”
por: Erdoğan, Mehmet, et al.
Publicado: (2022)

Liver manifestations in COVID-19 patients: A review article
por: Helou, Mariana, et al.
Publicado: (2023)

Do Lifestyle Changes of Renal Transplant Recipients During the Pandemic Reduce the Risk of Coronavirus Disease 2019?
por: Hasanoglu, Imran, et al.
Publicado: (2020)

Pancreatic transplantation: Brief review of the current evidence
por: Aref, Ahmed, et al.
Publicado: (2019)

Review on hepatitis B virus precore/core promoter mutations and their correlation with genotypes and liver disease severity
por: Kumar, Rajesh
Publicado: (2022)

COVID-19 and Sepsis
por: KOÇAK TUFAN, Zeliha, et al.
Publicado: (2021)

Functional magnetic resonance imaging and the brain: A brief review
por: Chow, Maggie S M, et al.
Publicado: (2017)

Epidemiology and etiology of chemical ocular injury: A brief review
por: Akgun, Zeynep, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature
por: De Carlis, Riccardo, et al.
Publicado: (2021)

Drug-induced liver injury and COVID-19: A review for clinical practice
por: Ortiz, Gabriela Xavier, et al.
Publicado: (2021)

Impact of COVID-19 on liver
por: Su, Yu-Jang, et al.
Publicado: (2021)

COVID-19 impact on the liver
por: Baroiu, Liliana, et al.
Publicado: (2021)

Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic
por: KOÇAK TUFAN, Zeliha, et al.
Publicado: (2020)

Progress in interventional radiology treatment of pulmonary embolism: A brief review
por: Posa, Alessandro, et al.
Publicado: (2022)

Liver and COVID-19: From care of patients with liver diseases to liver injury
por: Gaspar, Rui, et al.
Publicado: (2021)

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
por: Okumuş, Nurullah, et al.
Publicado: (2021)

Liver injury in COVID-19: A minireview
por: Zhao, Jian-Nan, et al.
Publicado: (2020)

Liver injury in COVID-19: A minireview
por: Hu, Wen-Shu, et al.
Publicado: (2022)

Liver injury in the era of COVID-19
por: Cichoż-Lach, Halina, et al.
Publicado: (2021)

Liver function in COVID-19 infection
por: Przekop, Dagmara, et al.
Publicado: (2021)

COVID-19 and the liver: Are footprints still there?
por: Gupta, Tarana, et al.
Publicado: (2023)

Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review
por: Khosla, Divya, et al.
Publicado: (2022)

COVID-19 pandemic: Its impact on liver disease and liver transplantation
por: Sahin, Tevfik Tolga, et al.
Publicado: (2020)

Liver-spleen axis dysfunction in COVID-19
por: Cococcia, Sara, et al.
Publicado: (2021)

Liver injury in COVID-19: Known and unknown
por: Zhou, Feng, et al.
Publicado: (2021)

COVID-19 in normal, diseased and transplanted liver
por: Signorello, Alessandro, et al.
Publicado: (2021)

Liver in the limelight in the corona (COVID-19) time
por: Chela, Harleen Kaur, et al.
Publicado: (2020)

COVID-19 related liver injuries in pregnancy
por: Sekulovski, Metodija, et al.
Publicado: (2023)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021)

Liver injury in COVID-19: Detection, pathogenesis, and treatment
por: Cai, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sk5cjntotm783h47jfil2tia9s